Francesca Offredi

Francesca Offredi

Auto-generated profile, based on publicly available information

Francesca Offredi

Research Center for Pediatric Epilepsies Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2026 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
MZMartina Paola Zanaboni
Martina Paola Zanaboni
CCCinzia Correale
Cinzia Correale
TMTiziana Metitieri
Tiziana Metitieri
VMValentina Manfredi
Valentina Manfredi
FOFrancesca Offredi
Francesca Offredi
SCSimona Cappelletti
Simona Cappelletti

18 August 2026 in Epilepsia
Verified
Journal Article
Open access
PDF file
BBBernardo Dalla Bernardina
Bernardo Dalla Bernardina
FOFrancesca Offredi
Francesca Offredi
ATAlessio Toraldo
Alessio Toraldo
LOLisa Ouss
Lisa Ouss
DBDelphine Breuillard
Delphine Breuillard
RNRima Nabbout
Rima Nabbout
Objective: The Dravet Disease‐Associated Neuropsychiatric Disorders (D‐DAND) scale is a new caregiver‐administered interview designed to assess the wide range of developmental and behavioral comorbidities in Dravet syndrome (DS) beyond seizures. D‐DAND's preliminary psychometric properties in a large patient sample are reported. Methods: D‐DAND was developed by a panel of experts and later standardized with caregivers of 123 individuals with DS (age = 3–41 years); a subsample of 43 caregivers were interviewed twice (~2 weeks apart) to evaluate test–retest reliability; another subsample of 80 were also administered with other scales that are widely used despite not being tailored to DS (Vineland Adaptive Behavior Scales, Child Behavior Checklist, Childhood Autism Rating Scale, Behavior Rating Inventory of Executive Function, Sleep Disturbance Scale for Children). Results: The D‐DAND captured a broad spectrum of abilities and dysfunctions across multiple functional domains. Test–retest reliability was excellent (overall score: r ≈ .98, median across domains: r ≈ .89), thus allowing for high sensitivity to time‐related changes. As expected, D‐DAND scores showed high correlations with some standardized measures (e.g., Vineland scales) and low correlation with others, suggesting that D‐DAND measures unique, Dravet‐specific features that other, widely used tools fail to detect. Significance: D‐DAND is a novel, reliable tool for comprehensive evaluation of DS beyond seizures. It enables systematic tracking of developmental and behavioral issues in DS, facilitating early identification of needs and more personalized, whole‐person care.